Furthermore, we detected and analyzed the expression of ASS1 in clinical human breast cancer tissue samples by immunohistochemistry (Fig. 5g), we found that the down-regulation of ASS1 expression in human breast cancer was significantly correlated with tumor recurrence within three years after surgery and adjuvant therapy (Fig. 5h). Here, ASS1 is linked to breast cancer.